Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,414.00 GBX | +1.33% |
|
+1.73% | +5.01% |
08/07 | Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs | MT |
08/07 | Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs | MT |
Main competitors
Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
---|---|---|---|---|---|---|---|
3.93TCr | 8.21% | 29.16% | 48.09% | 10.97% | 1.22x | ||
4.5TCr | 23.51% | 31.78% | 84.84% | 14.84% | 1.88x | ||
8.88TCr | 15.84% | 29.8% | 34.23% | 13.95% | 0.36x | ||
5.63TCr | 7.59% | 41.43% | 263.08% | 13.34% | 2.56x | ||
4.03TCr | 34.78% | 44.19% | 80.78% | 25.88% | 0.52x | ||
6.68TCr | 13.68% | 34.42% | 43.45% | 15.69% | 0.74x | ||
5.03TCr | 23.73% | 38.74% | 34.74% | 15.58% | 0.85x | ||
5.41TCr | 13.01% | 31.31% | 32.11% | 12.51% | 1.47x | ||
6.42TCr | 26.68% | 36.46% | 46.35% | 17.38% | 0.86x | ||
3.34TCr | 12.24% | 44.96% | 177.29% | 11.36% | 2.33x | ||
6.36TCr | 12.62% | 34.24% | 19.99% | 8.05% | 1.52x | ||
2.88TCr | 1.67% | 29.63% | 27.6% | 9.57% | 1.48x | ||
1.1TCr | -4.86% | 6.31% | 0.65% | 0.49% | -6.77x | ||
4.25TCr | 13.98% | 27.61% | 11.75% | 4.43% | 0.68x | ||
4.83TCr | -18.53% | 10.77% | 10.23% | -9.53% | 6.49x | ||
744.57Cr | 33.09% | 46.3% | 22% | 18.71% | -1.74x | ||
383.4Cr | 22.64% | 26.77% | 14.73% | 13.49% | -2.98x | ||
3.06TCr | 2.36% | 7.48% | 1.5% | 1.19% | 3.6x | ||
1.41TCr | 12.84% | 22.26% | 8.8% | 4.22% | 2.82x | ||
Average | 4.15TCr | 13.42% | 30.19% | 50.64% | 10.64% | 0.94x | |
Weighted average by Cap. | 5TCr | 16.6% | 33.21% | 71.29% | 13.3% | 1.12x |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition